Skip to main content

Danaher Extends Offer for Beckman Coulter for Third Time

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Danaher on Tuesday extended for a third time its cash tender offer for Beckman Coulter.

The offer to acquire all outstanding shares of Beckman Coulter is now set to expire on June 24, 5 p.m., New York City time. It had been scheduled to expire at midnight June 6.

The company said that it anticipates regulatory approval of the $6.8 billion deal from the European Commission on or about June 16, and to close on it before the end of June. As of 4 p.m. on May 31, more than 25 million shares of Beckman Coulter's stock had been validly tendered and not withdrawn, Danaher said.

The Scan

WHO OKs Emergency Use of Sinopharm Vaccine

The World Health Organization has granted emergency approval for Sinopharm's SARS-CoV-2 vaccine, the Guardian reports.

Scientific Integrity Panel to Meet

According to the Associated Press, a new US scientific integrity panel is to meet later this week.

Trying in the Eye

NPR reports that a study of Editas Medicine's CRISPR therapy for Leber congenital amaurosis has begun.

PLOS Papers on Cerebellum Epigenetics, Copy Number Signature Tool, Acute Lung Injury Networks

In PLOS this week: epigenetics analysis of brain tissue, bioinformatics tool to find copy number signatures in cancer, and more.